Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

LST1 Activators

The chemical class designated as LST1 Activators consists of a diverse array of compounds that potentially modulate the activity of LST1 (Leukocyte-Specific Transcript 1), a protein implicated in immune system responses and inflammatory processes. This class is primarily composed of molecules that activate or influence signaling pathways in the immune system, which, in turn, may have an indirect impact on LST1 activity. These compounds include various agonists of Toll-like receptors (TLRs) and other molecules involved in innate immune signaling. For instance, compounds like PMA (Phorbol 12-Myristate 13-Acetate) and LPS (Lipopolysaccharides) are known to activate specific signaling pathways such as Protein Kinase C and Toll-like receptors, respectively. The activation of these pathways can potentially influence the activity of LST1, given its role in modulating immune responses. Similarly, TLR agonists like CpG Oligodeoxynucleotides, Imiquimod, Poly(I:C), and R848 target different aspects of the immune system's response to external stimuli, potentially impacting the activity of LST1 through their engagement with these critical receptors.

Additionally, this chemical class includes compounds that stimulate TLRs involved in recognizing specific pathogen-associated molecular patterns, such as Flagellin, Gardiquimod, Resiquimod, Pam3CSK4, and Muramyl Dipeptide. Each of these compounds has a unique mechanism of action, targeting different TLRs or other immune receptors, which can indirectly influence LST1 activity. For example, Flagellin, as a TLR5 agonist, may impact LST1 activity in bacterial immune responses, while Gardiquimod and Resiquimod, as TLR7/8 agonists, could affect LST1 in the context of viral defense mechanisms. The activation of these receptors and subsequent signaling cascades highlights the potential of these compounds to modulate immune and inflammatory responses where LST1 is involved. The LST1 Activators class, therefore, represents a collection of compounds that, through their varied roles in activating or influencing immune signaling pathways, have the capacity to indirectly affect the activity of the LST1 protein. This class exemplifies the intricate interplay within the immune system, where modulation of specific receptors and signaling molecules can have broader implications for the regulation of proteins involved in immune responses.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates Protein Kinase C, could influence signaling pathways involving LST

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$98.00
$171.00
$425.00
$1560.00
12
(2)

Can activate Toll-like receptors, potentially impacting LST1 activity in immune response.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$67.00
$284.00
6
(1)

TLR7 agonist, could enhance pathways involving LST1 in immune response.

Polyinosinic-polycytidylic acid potassium salt

31852-29-6sc-202767
5 mg
$198.00
(1)

TLR3 agonist, might influence LST1 activity in antiviral responses.

R-848

144875-48-9sc-203231
sc-203231A
sc-203231B
sc-203231C
5 mg
25 mg
100 mg
500 mg
$102.00
$306.00
$510.00
$1559.00
12
(1)

Can activate TLR7/8, potentially impacting LST1 in immune signaling.

Gardiquimod

1020412-43-4sc-221663
sc-221663A
sc-221663B
sc-221663C
sc-221663D
sc-221663E
sc-221663F
25 mg
50 mg
100 mg
250 mg
5 g
10 g
25 g
$157.00
$282.00
$516.00
$1177.00
$20138.00
$32779.00
$70753.00
1
(1)

TLR7 agonist, might impact LST1 in immune response pathways.

Pam3Cys-Ser-(Lys)4, Hydrochloride

112208-00-1sc-507471
2 mg
$550.00
(0)

TLR1/2 agonist, could influence LST1 activity in immune responses.